ELF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ELF is not a good buy right now for a beginner long-term investor with $50,000-$100,000 and an impatient entry style. The stock has bounced recently, but the current setup is mixed: technicals are extended, analyst sentiment is getting more cautious, insiders are selling, and there is no strong proprietary buy signal. I would not call this a clear long-term buy at the current price of 76.37. If already owned, holding is reasonable; if not owned, I would wait rather than buy now.
Price is near the upper part of the recent range with pivot at 70.214 and resistance at 77.426, so the stock is approaching near-term resistance. MACD histogram is positive at 1.723 but contracting, which suggests upside momentum is slowing. RSI_6 at 77.005 indicates the stock is overbought rather than offering a clean entry. Moving averages are converging, which usually reflects a lack of strong trend acceleration. Overall, the trend is mildly bullish short term, but the current price looks stretched and not ideal for an immediate buy.
Recent news shows shares rose 5.9% on July 1 on confidence in the growth strategy. The company is gaining market share through its multi-brand portfolio and international expansion. Upcoming quarterly results are expected to deliver EPS of 0.73 and revenue of 424.55 million, which gives a near-term event catalyst. Analyst B. Riley still keeps a Buy rating despite cutting its target, and TD Cowen still has a Buy rating, showing some continued support from bulls.
Consensus EPS estimates were cut by 6.6% over the last 30 days, which is a clear negative earnings sentiment shift. Several firms have turned more cautious: Deutsche Bank and Bernstein are Hold/Market Perform, Morgan Stanley downgraded to Equal Weight, and multiple price targets were sharply reduced. Insider selling has increased dramatically, up 3611.29% over the last month, which is a bearish signal. Hedge funds are neutral, and there is no supportive congress trading data or influential buying activity.
No full financial statement data was provided, so I cannot assess detailed latest-quarter revenue or margin trends. From the news summary, the upcoming quarter is expected to report EPS of 0.73 and revenue of 424.55 million, which implies the latest quarter focus is on growth and market-share gains, but expectations have been lowered recently. That suggests growth remains present, but the market is less confident in near-term earnings quality and consistency.
Analyst sentiment has softened over the last several weeks. Deutsche Bank raised its target slightly but kept Hold, Bernstein initiated at Market Perform, Morgan Stanley downgraded to Equal Weight, and several firms sharply cut targets, though B. Riley, Canaccord, Baird, and TD Cowen still maintain bullish ratings. The overall Wall Street view is mixed-to-cautious: bulls point to brand growth, Rhode momentum, and international expansion, while bears focus on slowing core cosmetics growth, reinvestment pressure, valuation compression, and a softer FY27 outlook.
